Meisner Derek M bought ABOS

January 16, 2026 · Form 4 insider transaction

Meisner Derek M bought 99,133 shares of Acumen Pharmaceuticals, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 5 days after the transaction.

Direction
Acquired (buy-side)
Shares
99,133
Price
$0.00
Total value
N/A
Role—
SecurityCommon Stock
Transaction codeA: Grant or award
Transaction dateJanuary 16, 2026
Filing dateJanuary 21, 2026
Shares owned after182,933
OwnershipDirect
10b5-1 planNo
AmendedNo

Footnotes

Represents a restricted stock unit ("RSU") award. Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. The RSUs will vest in three equal annual installments commencing one year after the grant date, subject to the Reporting Person's continuous service through each such vesting date.

View the original Form 4 on SEC EDGAR
Meisner Derek M bought ABOS: January 16, 2026 | Insider Trading Screener